Navigation Links
22 of America's most promising scientists selected as Pew Biomedical Scholars
Date:6/13/2012

PHILADELPHIA Twenty-two of the nation's most innovative young researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The Scholars join a prestigious community that includes Nobel Prize winners, MacArthur Fellows, and recipients of the Albert Lasker Medical Research Award.

"During these challenging budgetary times when traditional sources of funding are becoming even harder for scientists to obtain, we are proud to back our country's most promising scientists," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts. "This funding comes at points in the Scholars' professional lives when they often are the most innovative. While this program is a bold investment for us, it has paid incalculable dividends due to our Scholars' record of producing groundbreaking research." The new class of scholars is exploring a range of human health issues from antibiotic-resistant infections to liver disease and cancer.

Launched in 1985, the Pew Scholars Program in the Biomedical Sciences identifies and invests in talented researchers in medicine or biomedical sciences. In that time, over 500 Pew Scholars have received more than $130 million in funding. By backing them early in their careers, this program enables our most promising scientists to take calculated risks and follow unanticipated leads to advance human health. "Giving young scientists the means and the confidence to pursue outside-the-box research is vital to the advancement of biomedical science," said Craig C. Mello, Ph.D., a 1995 Pew Scholar and a 2006 Nobel Laureate in Physiology or Medicine. "The Pew Scholars Program in the Biomedical Sciences was a critical step in my career, and as Chair of the national advisory committee, and I am honored to welcome the 2012 awardees into a family of scientists eager to share ideas and to collaborate for years to come."

The program is rigorously competitive, and recipients receive $240,000 over four years to pursue their research without restriction. To be considered, applicants from all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 179 institutions were requested to nominate a candidate, and 134 eligible nominations were received.

The initiative is run by The Pew Charitable Trusts, which also directs the Pew Latin American Fellows in the Biomedical Sciences, a program that for 21 years has provided support for young scientists from Latin America to receive postdoctoral training in the United States.

The new 2012 Pew Scholars are:

Dinu Florin Albeanu, Ph.D.
Cold Spring Harbor Laboratory
Neuroscience

Peter V. Cornish, Ph.D.
University of Missouri
Biochemistry and Biophysics

Maximiliano A. D'Angelo, Ph.D.
University of California, San Francisco
Cell Biology

D. Allan Drummond, Ph.D.
University of Chicago
Biochemistry and Molecular Biology

Nels C. Elde, Ph.D.
University of Utah
Evolutionary Genetics, Cell Biology

Donald Fox, Ph.D.
Duke University Medical Center
Tissue Repair and Genome Stability

Robert C. Froemke, Ph.D.
Skirball Institute, New York University
School of Medicine
Neuroscience

Wolfram Goessling, M.D., Ph.D.
Dana-Farber Cancer Institute
Developmental and Regenerative Biology

Xue Han, Ph.D.
Boston University
Neuroscience

Ivaylo I. Ivanov, Ph.D.
Columbia University Medical Center
Immunology

Salil A. Lachke, Ph.D.
University of Delaware
Developmental Genetics

Saskia B. Neher, Ph.D.
University of North Carolina, Chapel Hill
Protein Biochemistry

Lorin E. Olson, Ph.D.
Oklahoma Medical Research Foundation Developmental and Regenerative Biology

Kevin K. Park, Ph.D.
University of Miami Miller School of Medicine
Neuroscience

Sohini Ramachandran, Ph.D.
Brown University
Human Genomics and Evolution

Vanessa Ruta, Ph.D.
The Rockefeller University
Neuroscience

Aimee Shen, Ph.D.
University of Vermont
Microbiology

Alexander Sher, Ph.D.
University of California, Santa Cruz
Neuroscience

Alexander V. Statsuk, Ph.D.
Northwestern University
Chemical Biology

Kathryn E. Wellen, Ph.D.
University of Pennsylvania
Cancer Metabolism and Epigenetics

Mee-Ngan F. Yap, Ph.D.
Saint Louis University
Molecular Microbiology

Wenjun Zhang, Ph.D.
University of California, Berkeley
Chemical and Synthetic Biology


'/>"/>

Contact: Nicolle Grayson
ngrayson@pewtrusts.org
202-540-6347
Pew Health Group
Source:Eurekalert

Related biology news :

1. First complete full genetic map of promising energy crop
2. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
3. Promising developments in early diagnosis and treatment of mesothelioma
4. Ultrasensitive biosensor promising for medical diagnostics
5. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
6. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
7. Queens scientists seek vaccine for Pseudomonas infection
8. Scientists produce eye structures from human blood-derived stem cells
9. American Society of Plant Biologists honors early career women scientists
10. Brandeis scientists win prestigious prize for circadian rhythms research
11. Scientists discover new method of proton transfer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
Breaking Biology Technology: